Objective: To examine whether the polymorphisms of endothelial nitric oxide synthase (eNOS) gene are associated with the susceptibility to high altitude pulmonary edema (HAPE) in Chinese railway construction workers at Qinghai-Tibet where the altitude is over 4 500 m above sea level.

Methods: A case-control study was conducted including 149 HAPE patients in the construction workers and 160 healthy controls randomly recruited from their co-workers, matching the patients in ethnicity, age, sex, lifestyle, and working conditions. Three polymorphisms of eNOS gene, T-786C in promoter, 894G/T in exon 7, and 27bp variable number tandem repeat (VNTR) in intron 4, were genotyped using polymerase chain reaction (PCR) and confirmed with DNA sequencing.

Results: The frequencies of 894T allele and heterozygous G/T of the 894G/T variant were significantly higher in HAPE patients group than in the control group (P=0.0028 and P=0.0047, respectively). However, the frequencies of the T-786C in promoter and the 27bp VNTR in intron 4 were not significantly different between the two groups. Haplotypic analysis revealed that the frequencies of two haplotypes (H3,T-T-b, b indicates 5 repeats of 27 bp VNTR; H6, C-G-a, a indicates 4 repeats of 27 bp VNTR) were significantly higher in HAPE patients (both Pü0.0001). On the contrary, the frequencies of H1 (T-G-b) and H2 (T-G-a) were lower in HAPE patients than in healthy controls (both Pü0.001).

Conclusions: Two haplotypes (T-T-b and C-G-a) may be strongly associated with susceptibility to HAPE. Compared with the individual alleles of eNOS gene, the interaction of multiple genetic markers within a haplotype may be a major determinant for the susceptibility to HAPE.

Download full-text PDF

Source
http://dx.doi.org/10.1016/s1001-9294(11)60005-9DOI Listing

Publication Analysis

Top Keywords

hape patients
16
associated susceptibility
12
construction workers
12
enos gene
12
endothelial nitric
8
nitric oxide
8
oxide synthase
8
susceptibility high
8
high altitude
8
altitude pulmonary
8

Similar Publications

High-altitude pulmonary edema (HAPE) is a life-threatening altitude sickness afflicting certain individuals after rapid ascent to high altitude above 2500 m. In the setting of HAPE, an early diagnosis is critical and currently based on clinical evaluation. The aim of this study was to utilize the metabolomics to identify the altered metabolic patterns and potential biomarkers for HAPE.

View Article and Find Full Text PDF

Introduction—: Mount Aconcagua (6961 m) in Argentina is the highest peak in the Americas, and more than 3000 climbers attempt to summit annually. High altitude pulmonary edema (HAPE) is a leading cause of mortality and evacuation on Aconcagua.

Objective—: This study sought to describe the characteristics of climbers who developed HAPE on Aconcagua to aid in future prevention efforts.

View Article and Find Full Text PDF
Article Synopsis
  • High altitude (HA) can induce various illnesses like high altitude pulmonary edema (HAPE) in unacclimatized individuals, impacting their health significantly.
  • This study focuses on circulating cell free (cf) DNA as a biomarker for HAPE, finding higher cfDNA levels in HAPE patients compared to healthy controls and highlanders, which correlates with inflammation.
  • Additionally, elevated markers of cell death and oxidative DNA damage in HAPE patients suggest that cfDNA fragments might contribute to the inflammatory response and understanding HAPE's pathophysiology.
View Article and Find Full Text PDF

Decoding the Immune Response and Its Biomarker B2M for High Altitude Pulmonary Edema in Rat: Implications for Diagnosis and Prognosis.

J Inflamm Res

October 2024

Department of Stem Cell and Regenerative Medicine, National Key Laboratory of Trauma and Chemical Poisoning, Daping Hospital, Army Medical University, Chongqing, 400042, People's Republic of China.

Article Synopsis
  • * Using bioinformatics and animal experiments, researchers found that low levels of B2M are linked to reduced immune function and increased expression of immune checkpoint molecules in patients with HAPE.
  • * Results suggest that measuring B2M levels in peripheral blood could help with diagnosing, assessing treatment effectiveness, and predicting outcomes for HAPE patients.
View Article and Find Full Text PDF
Article Synopsis
  • HAPE is a serious condition that can occur in individuals reaching heights above 9000 ft, typically affecting both lungs, but rare cases can show unilateral involvement, usually in the right lung.
  • A case study of a young man with HAPE showing unilateral left lung symptoms revealed severe dyspnea, hypoxemia, and tachycardia, after he returned to a high-altitude area.
  • Treatment resulted in a full recovery within five days, emphasizing the importance of recognizing unusual HAPE presentations for effective intervention and patient outcomes.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!